SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-15-001081
Filing Date
2015-03-11
Accepted
2015-03-11 16:23:57
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT sbfm_10k.htm 10-K 1284759
2 CERTIFICATE sbfm_exh311.htm EX-31.1 17401
3 CERTIFICATE sbfm_exh312.htm EX-31.2 17228
4 CERTIFICATE sbfm_exh321.htm EX-32.1 11775
5 img1.jpg GRAPHIC 27657
6 img2.jpg GRAPHIC 29959
7 img3.jpg GRAPHIC 22988
8 img4.jpg GRAPHIC 20836
  Complete submission text file 0001354488-15-001081.txt   3071077

Data Files

Seq Description Document Type Size
9 sbfm-20141231.xml EX-101.INS 210209
10 sbfm-20141231.xsd EX-101.SCH 19929
11 sbfm-20141231_cal.xml EX-101.CAL 26886
12 sbfm-20141231_def.xml EX-101.DEF 31424
13 sbfm-20141231_lab.xml EX-101.LAB 125673
14 sbfm-20141231_pre.xml EX-101.PRE 93420
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52898 | Film No.: 15693037
SIC: 8742 Services-Management Consulting Services